Connect with us

News

NFL funds $1 million research into medical cannabis and pain

The move is the next step in a shifting attitude towards players who use medicinal cannabis

Published

on

For years the NFL suspended players who tested positive for cannabis use

The National Football League (NFL) in America is providing $1 million in funding for research into pain management and cannabinoids.

The pain management committee of the NFL and the NFL Players Association announced it would stump up the funding on Tuesday 8 June.

According to the organisation’s news platform, the move is the next step in a shifting attitude towards players who use medicinal cannabis to manage pain from injuries.

 

For years the NFL suspended players who tested positive for cannabis use, despite many maintaining that it is safer than commonly-prescribed opioids.

The NFL-NFLPA Pain Management Committee (PMC) was formed as part of a Collective Bargaining Agreement over a year ago, with the goal of benefitting the health and safety of NFL players through education and research.

Last year it conducted two informational forums on CBD to learn about the current state of CBD science and manufacturing in the US, as part of its aim to find alternatives to opioids in the pain management of players.

Earlier this year, the PMC made a formal request for information on “pain management alternatives to opioids”.

At the time, the NFL said it was seeking out qualified researchers who could lead studies into pain management and athletic performance

Up to five grants are expected to be awarded later this year.

Dr Kevin Hill, the co-chair of the pain management committee and director of addiction psychiatry at Beth Israel Deaconess Medical Centre, said the level of interest in the use of medical cannabis “far exceeds” the amount of evidence available.

NFL.com reported that the committee has heard “mixed results” from players about using marijuana to treat pain and Hill. believes it could be “riskier” than people realise. 

“There is a need for better information, better science,” Hill said.

“When we talk about having elite athletes use CBD to treat pain, we want to make sure it’s No. 1 safe, and No. 2 efficacious. I don’t think we’re at that point yet.”

 

 

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.